Claudin-6

Claudin-6

Claudin-6 Molekülinformation

Molecule Name
Claudin 6
Molekülalias
Claudin-6,CLDN6
Drug Development Progress
Anzahl der klinischen Arzneimittel13
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
UNQ757/PRO1488,Claudin-6,CLDN6,Claudin 6,Skullin
Molekülhintergrund
Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. Claudin-6, also knows as CLDN6, is a multipass transmembrane protein in the Claudin family. Claudin-6 is expressed by epithelial cells where it participates in tissue development and the maintenance of tight junction integrity. And it is one of the entry cofactors for hepatitis C virus. The methylation of CLDN6 may be involved in esophageal tumorigenesis. The gene of CLDN6 is adjacent to another family member CLDN9 on chromosome 16.

Claudin-6 Produktliste

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Antikörperprojekt-Handelsplattform

ProjektnameProjektphaseMolekültypMolekülquelleKrankheitsgebietIndikationen
CLDN6 mAb - 01PCCMonoclonalHumanized MouseSolid TumorOvarian cancer,Lung adenocarcinoma
Projektname
CLDN6 mAb - 01
Projektphase
PCC
Molekültyp
Monoclonal
Molekülquelle
Humanized Mouse
Krankheitsgebiet
Solid Tumor
Indikationen
Ovarian cancer,Lung adenocarcinoma